Filed: 8/14/2024ACC: 0001012975-24-000339
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $266.02M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$266.02M
Total AUM (reported)
33.19M
Total Shares
Allocation by class
COM$263.17M98.9%
COM NEW$2.43M0.9%
CLASS A COM$431.8K0.2%
Portfolio Concentration
Top 3$240.35M90.3%
4–10$25.67M9.7%
Top 3 weight
90.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 33.19M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
33.19M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole9
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings9
Rows:
BEAM THERAPEUTICS INC.
SOLEShares5.44M
TypeSH
Market value$127.53M
47.94%
Sole
0.00
Shared
0.00
None
5.44M
RAPPORT THERAPEUTICS, INC.
SOLEShares3.73M
TypeSH
Market value$86.73M
32.60%
Sole
0.00
Shared
0.00
None
3.73M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$26.09M
9.81%
Sole
0.00
Shared
0.00
None
11.06M
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$9.80M
3.69%
Sole
0.00
Shared
0.00
None
2.01M
GOSSAMER BIO, INC.
SOLEShares8.06M
TypeSH
Market value$7.26M
2.73%
Sole
0.00
Shared
0.00
None
8.06M
Q32 BIO INC.
SOLEShares320.48K
TypeSH
Market value$5.75M
2.16%
Sole
0.00
Shared
0.00
None
320.48K
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$1.36M
0.51%
Sole
0.00
Shared
0.00
None
1M
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares126.63K
TypeSH
Market value$1.07M
0.40%
Sole
0.00
Shared
0.00
None
126.63K
CERO THERAPEUTICS HOLDINGS, INC.
SOLEShares1.44M
TypeSH
Market value$431.8K
0.16%
Sole
0.00
Shared
0.00
None
1.44M
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BEAM THERAPEUTICS INC.SOLE | COM | 5.44M | SH | $127.53M 47.94% | 0.00 | 0.00 | 5.44M |
RAPPORT THERAPEUTICS, INC.SOLE | COM | 3.73M | SH | $86.73M 32.60% | 0.00 | 0.00 | 3.73M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $26.09M 9.81% | 0.00 | 0.00 | 11.06M |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $9.80M 3.69% | 0.00 | 0.00 | 2.01M |
GOSSAMER BIO, INC.SOLE | COM | 8.06M | SH | $7.26M 2.73% | 0.00 | 0.00 | 8.06M |
Q32 BIO INC.SOLE | COM | 320.48K | SH | $5.75M 2.16% | 0.00 | 0.00 | 320.48K |
UNITY BIOTECHNOLOGY, INC.SOLE | COM NEW | 1M | SH | $1.36M 0.51% | 0.00 | 0.00 | 1M |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM NEW | 126.63K | SH | $1.07M 0.40% | 0.00 | 0.00 | 126.63K |
CERO THERAPEUTICS HOLDINGS, INC.SOLE | CLASS A COM | 1.44M | SH | $431.8K 0.16% | 0.00 | 0.00 | 1.44M |